Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-16

Clinical Trial Update: Fluoxetine for Motor, Aphasia, and Neglect Recovery After Ischemic Stroke [NA]

View source ↗

Summary

A clinical trial evaluating fluoxetine for motor, aphasia, and neglect recovery after ischemic stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: Spaulding Rehabilitation Hospital | Conditions: Stroke | NA | Status: WITHDRAWN